USPTO Examiner KIM ERIN ASA - Art Unit 3781

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19386177DEVICES, SYSTEMS, AND METHODS FOR MANAGING BLOOD FLOWNovember 2025March 2026Allow400NoNo
19263935CatheterJuly 2025October 2025Allow300NoNo
19256472URINE COLLECTION SYSTEMS, AND METHODS OF MAKING AND USING THE SAMEJuly 2025October 2025Allow310NoNo
19210550Wearable Urinary Collection ApparatusMay 2025July 2025Allow200NoNo
19173518DEVICES, SYSTEMS, AND METHODS FOR REVASCULARIZATION OF THE MYOCARDIUMApril 2025September 2025Allow510YesNo
19098279DEVICES, SYSTEMS, AND METHODS FOR MANAGING BLOOD FLOWApril 2025August 2025Allow400NoNo
19066822BLOOD TRANSFUSION FOR THROMBECTOMY DEVICES, AND SYSTEMS AND METHODS THEREOFFebruary 2025August 2025Allow611NoNo
19042647Wearable Urinary Collection ApparatusJanuary 2025April 2025Allow300NoNo
19009028Cerebrospinal Fluid Shunt With Flow RegulationJanuary 2025November 2025Allow1110NoNo
18927053NEGATIVE PRESSURE BANDAGEOctober 2024January 2025Allow300NoNo
18917388HYBRID DEVICES WITH DIMENSIONS THAT CAN BE ADJUSTED IN VIVO AND METHODS OF MANUFACTURING THEREOFOctober 2024January 2025Allow300NoNo
18887672BAFFLE DEVICES AND RELATED METHODS FOR DELIVERY OF THERAPEUTIC COMPOSITIONS TO THE EYESeptember 2024January 2025Allow410NoNo
18705844ATRIAL SHUNT DEVICE, MANUFACTURING METHOD, AND ATRIAL SHUNT SYSTEM USING SHUNT DEVICEApril 2024January 2025Allow910YesNo
18705324OSTOMY POUCH CLOSURE SYSTEMApril 2024November 2024Allow720NoNo
18636797EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND METHOD FOR MONITORING PRESSURES IN AN EXTRACORPOREAL BLOOD TREATMENT APPARATUSApril 2024October 2025Allow1810NoNo
18405565BODY FLUID MOVEMENT SYSTEM WITH ONE OR MORE SENSORS COUPLED TO A PATIENT REMOTE MONITORING SYSTEMJanuary 2024December 2024Allow1220YesNo
18558428SYRINGE WITH LUER-LOCK CONNECTOR PROVIDED WITH A TAMPER-PROOF CAPNovember 2023February 2026Allow2800NoNo
18555476INSERTION TOOL FOR AN EYE DISEASE TREATMENT DEVICEOctober 2023January 2026Allow2700NoNo
18263460CUP FOR AUTOMATIC EXCRETION TREATING APPARATUS AND AUTOMATIC EXCRETION TREATING APPARATUSJuly 2023November 2025Allow2810NoNo
18265130UNDERPANTS-TYPE DISPOSABLE WEARING ARTICLEJune 2023September 2025Allow2700NoNo
18254133IMPLANTABLE OCULAR DRAINAGE DEVICE FOR CONTROLLING INTRAOCULAR PRESSUREMay 2023February 2026Allow3310NoNo
18198303ABSORBENT ARTICLEMay 2023December 2025Allow3110YesNo
18303867ABSORBENT ARTICLESApril 2023March 2026Abandon3510NoNo
18028786MEDICAL APPLIANCEMarch 2023September 2025Allow3000NoNo
18105668SYSTEMS AND METHODS FOR THE CONDITIONING OF CEREBROSPINAL FLUIDFebruary 2023November 2025Allow3300NoNo
17993590Flexible Medical Device Holders and Methods for UseNovember 2022January 2026Abandon3810NoNo
17981573Morning Erections Urine Collection DeviceNovember 2022November 2025Abandon3710NoNo
17920427SYSTEM OF A PULL-ON WEARABLE ARTICLE AND AN ABSORBENT ARTICLEOctober 2022December 2025Allow3720NoNo
18048093SELF-ADHESIVE SANITARY PRODUCT AND PREPARATION METHOD THEREOFOctober 2022April 2025Allow2900NoNo
17919226POWER MANAGEMENT FOR INTERATRIAL SHUNTS AND ASSOCIATED SYSTEMS AND METHODSOctober 2022June 2025Allow3200NoNo
17996064FEMALE EXTERNAL CATHETER DEVICES HAVING A URETHRAL CUP, AND RELATED SYSTEMS AND METHODSOctober 2022July 2025Allow3410YesNo
17995723INFUSING DISSOLVED OXYGEN INTO I.V. FLUIDS TO PROVIDE SHORT TERM EMERGENCY OXYGENATION OF VENOUS BLOOD FOR COMPROMISED OR TRAUMA PATIENTSOctober 2022February 2026Allow4011YesNo
17917319RESPONSIVE ABSORBENT ARTICLESOctober 2022November 2025Allow3720YesNo
17917457METHOD FOR PRODUCING AN IMPLANT FOR INSERTING INTO AN EYE, IN PARTICULAR FOR INSERTING INTO THE SCHLEMM'S CANAL OF AN EYEOctober 2022December 2025Abandon3801NoNo
17907125MULTI-LAYER URINE CAPTURE DEVICE AND RELATED METHODSSeptember 2022September 2025Allow3620YesNo
17800792A COLLECTING DEVICEAugust 2022April 2025Allow3210NoNo
17795661MEDICAL FLUID THERAPY SYSTEM AND METHOD EMPLOYING DISTILLATIONJuly 2022March 2025Allow3200NoNo
17759172Lymphatic Access, Drainage, And ShuntingJuly 2022May 2025Abandon3410NoNo
17868092URINE COLLECTION SYSTEMS, AND METHODS OF MAKING AND USING THE SAMEJuly 2022March 2025Allow3210YesNo
17793504MEDICAL DEVICES FOR SHUNTS, OCCLUDERS, FENESTRATIONS AND RELATED SYSTEMS AND METHODSJuly 2022August 2025Allow3711YesNo
17793338DEVICES CONTAINING CELLULAR MEMBRANE AND USES THEREOFJuly 2022April 2025Allow3310YesNo
17758316URINE COLLECTION DEVICES HAVING A RELATIVELY WIDE PORTION AND AN ELONGATED PORTION AND RELATED METHODSJuly 2022March 2025Allow3310YesNo
17786538OSTOMY SYSTEM FOR PREDICTING A SITE OF LEAKAGEJune 2022April 2025Allow3410NoNo
17778912INCONTINENCE & STOMA SCENT PATCHMay 2022April 2025Allow3510NoNo
17774190SYRINGE-SHAPED SPRAYING DEVICEMay 2022March 2025Allow3510NoNo
17773200SYSTEMS AND METHODS FOR NEUROVASCULAR INTERVENTIONSApril 2022April 2025Allow3610YesNo
17771198PISTON VALVING FOR SERIALLY CONNECTABLE DRUG MODULES OF A COMBINATORIAL DRUG DELIVERY DEVICEApril 2022October 2024Allow3000NoNo
17717745CATHETERApril 2022November 2025Allow4320NoNo
17714767ARRANGEMENT FOR MODIFYING AN INTERNAL EYE PRESSURE IN VIVOApril 2022August 2025Allow4111NoNo
17708147Percutaneous Potts Shunt Devices and Related MethodsMarch 2022November 2025Allow4320NoNo
17702490MALE EXTERNAL CATHETERMarch 2022July 2025Abandon4010NoNo
17691300STRETCH LAMINATE FOR INCONTINENT DEVICEMarch 2022September 2025Allow4320YesNo
17689160DIAPER SET EQUIPPED WITH EXCRETA INDUCING SEATMarch 2022September 2024Allow3010NoNo
17688816BIODEGRADABLE TOBACCO-BASED ABSORBENT ARTICLEMarch 2022July 2024Abandon2910NoNo
17683943METHOD AND APPARATUS FOR HUMAN BRAIN NEUROPROTECTION DURING SURGERYMarch 2022February 2026Allow4711NoNo
17633596BAG SYSTEM FOR COLLECTING BLOOD FROM ANIMALSFebruary 2022November 2024Abandon3310NoNo
17597983DEVICE AND METHOD FOR PREPARING A DONOR ORGAN FOR TRANSPLANTATIONJanuary 2022February 2025Abandon3710NoNo
17583307REUSABLE SANITARY NAPKIN AND A COMBINED PANTY AND REUSABLE SANITARY NAPKIN UNDERWEARJanuary 2022August 2024Abandon3110NoNo
17582041ABSORBENT BODY WITH TOPSHEET COMPOSITEJanuary 2022February 2025Allow3730NoNo
17273371CONTAINER ARRANGEMENT, METHOD OF FILLING A CONTAINER ARRANGEMENT, AND USE OF A SOLUTION AS A DIALYSIS SOLUTIONJanuary 2022May 2025Allow5010NoNo
17558071COMPRESSION BODYSUIT RETRACTOR FOR BOWEL MOVEMENTDecember 2021August 2024Allow3220NoNo
17600274RESERVOIR ASSEMBLY FOR PROVIDING CARDIOPLEGIC SOLUTION CONTAINING BICARBONATE ION, AND METHOD FOR MANUFACTURING THE SAMEDecember 2021August 2025Allow4730NoNo
17542592ABSORBENT CORE COMPRISING A HIGH LOFT CENTRAL LAYER AND TWO DIFFERENT SUPERABSORBENT POLYMERSDecember 2021March 2025Allow3930NoNo
17615497SOURCE CONTAINER CONNECTORNovember 2021March 2025Allow3910NoNo
17607637DIALYSIS SYSTEMS AND METHODSOctober 2021April 2025Allow4110NoNo
17510660Nonwoven And Absorbent Articles Having The SameOctober 2021August 2025Allow4540NoNo
17509691DRUG SECURITY SYSTEMS AND METHODSOctober 2021September 2024Allow3510NoNo
17505508SYSTEM AND METHOD FOR A NURSING PADOctober 2021September 2024Abandon3520YesNo
17503983PROSTHETIC DEVICES FOR A DECEASED HUMAN BODY AND METHODS OF USE THEREOFOctober 2021September 2023Allow2200NoNo
17502286Automatic In Vitro Diagnostic Medical Device for Intraventricular DrainageOctober 2021March 2025Allow4130NoNo
17603173IMPROVED OXYGENATOR FOR USE WITH EXTRACORPOREAL SUPPORT OF PREMATURE FETUSOctober 2021December 2024Allow3810NoNo
17483404Fluid Transfer Device and Packaging ThereforSeptember 2021May 2025Allow4410NoNo
17435985ABSORBENT BODY, ABSORBENT ARTICLE AND METHOD FOR ADJUSTING PERMEATION SPEEDSeptember 2021October 2024Abandon3810NoNo
17434416A SENSOR PATCH FOR ATTACHMENT TO A BASE PLATEAugust 2021November 2024Allow3910YesNo
17434045EXTRACORPOREAL BLOOD LINE SET AND BLOOD TREATMENT MACHINEAugust 2021March 2025Allow4230NoYes
17434277IMPLANT COMPRISING COATING LAYER FOR OPHTHALMOPATHYAugust 2021October 2024Abandon3710NoNo
17400558SENSOR SYSTEM AND MEDICAL DEVICEAugust 2021February 2025Allow4220YesNo
17392930SELF-ADHESIVE ABSORBENT HYGIENIC PATCH WORN ON THE BODYAugust 2021April 2024Abandon3210NoNo
17310112INJECTION CANNULA, ECMO SYSTEMJuly 2021October 2024Allow3910NoNo
17423419METHOD AND DEVICE FOR TREATING EYE DISEASEJuly 2021July 2025Allow4820NoNo
17354388CEREBROSPINAL FLUID PURIFICATION SYSTEMJune 2021December 2024Allow4220YesNo
17350414ATTACHING MEMBERJune 2021September 2024Allow3910NoNo
17415582SYSTEM FOR CONTINUOUS RENAL REPLACEMENT THERAPYJune 2021March 2025Abandon4520NoNo
17349978HEMODIALYSIS SYSTEM INCLUDING CONTINUOUS GLUCOSE MONITORINGJune 2021September 2025Abandon5120NoNo
17325232Anti-permeable, anti-side leakage diapers, pull ups and training pants, and a production line for producing the sameMay 2021March 2024Abandon3401NoNo
17293570THERMALLY REGULATED TRANSDERMAL DRUG DELIVERY SYSTEMMay 2021April 2025Allow4720NoNo
17287100IMPLANTABLE DEVICE FOR TREATING HYPERVOLEMIAApril 2021October 2024Allow4210NoNo
17285250ELASTIC DIAPER ELEMENTApril 2021June 2025Allow5021NoNo
17283749EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND METHOD FOR MONITORING PRESSURES IN AN EXTRACORPOREAL BLOOD TREATMENT APPARATUSApril 2021January 2024Allow3300NoNo
17282397NEUROTOXIN PREFILLED VIALApril 2021August 2024Allow4020YesNo
17195707RECTAL INSERTION DEVICEMarch 2021May 2024Abandon3810NoNo
17178539OUTLET VALVE FOR AN OSTOMY APPLIANCEFebruary 2021February 2025Allow4811NoNo
17178302APERTURED SUBSTRATE AND ABSORBENT ARTICLES COMPRISING THE SAMEFebruary 2021December 2024Abandon4620NoNo
17173047INCONTINENCE PRODUCTFebruary 2021March 2024Abandon3710NoNo
17257653DISPOSABLE WEARABLE ARTICLEJanuary 2021June 2024Abandon4110NoNo
17257217SYSTEM AND METHOD FOR EXTRACORPOREAL CARBON MONOXIDE REMOVAL WITH PHOTOTHERAPYDecember 2020April 2024Allow3910NoNo
17250220Elastic Super Absorbent Polymer SheetDecember 2020April 2024Abandon4010NoNo
17252291MOISTURE ASSESSMENT SYSTEM FOR WOUND CAREDecember 2020May 2025Allow5340YesNo
16951312REUSABLE MENSTRUAL CUP FOR EASY REMOVAL WITHOUT PAINNovember 2020December 2023Allow3700NoNo
17092995Blood Treatment SystemsNovember 2020December 2025Abandon6021NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIM, ERIN ASA.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
10.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner KIM, ERIN ASA - Prosecution Strategy Guide

Executive Summary

Examiner KIM, ERIN ASA works in Art Unit 3781 and has examined 44 patent applications in our dataset. With an allowance rate of 65.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.

Allowance Patterns

Examiner KIM, ERIN ASA's allowance rate of 65.9% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by KIM, ERIN ASA receive 1.64 office actions before reaching final disposition. This places the examiner in the 32% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by KIM, ERIN ASA is 41 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +23.6% benefit to allowance rate for applications examined by KIM, ERIN ASA. This interview benefit is in the 70% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 40.0% of applications are subsequently allowed. This success rate is in the 91% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 30.0% of cases where such amendments are filed. This entry rate is in the 43% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 99% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.